RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
US Market
Holding RVLPQ?
Track your performance easily

RVL Pharmaceuticals (RVLPQ) Financial Statements

314 Followers

RVL Pharmaceuticals Financial Overview

RVL Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.697; its P/E ratio is -0.01; RVL Pharmaceuticals is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 8.26M$ 8.83M$ 9.81M$ 10.02M$ 8.45M
Gross Profit$ 6.31M$ 6.53M$ 7.25M$ 7.50M$ 6.22M
EBIT$ -20.84M$ -16.07M$ -19.47M$ -13.25M$ -10.85M
EBITDA$ -20.75M$ -15.98M$ -19.37M$ -13.16M$ -10.76M
Net Income Common Stockholders$ 7.05M$ -11.61M$ -18.32M$ -14.45M$ -12.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 32.60M$ 44.50M$ 59.75M$ 28.54M
Total Assets$ 85.40M$ 111.07M$ 128.51M$ 155.35M$ 124.83M
Total Debt$ 58.15M$ 57.75M$ 57.49M$ 56.66M$ 44.41M
Net Debt$ 58.15M$ 25.15M$ 12.99M$ -3.09M$ 15.87M
Total Liabilities$ 69.08M$ 71.11M$ 77.42M$ 86.81M$ 66.32M
Stockholders Equity$ 16.33M$ 40.03M$ 51.09M$ 68.55M$ 58.51M
Cash Flow-
Free Cash Flow-$ -7.03M$ -16.57M$ -10.12M$ 2.00M
Operating Cash Flow$ -12.08M$ -5.80M$ -16.40M$ -10.10M$ 2.00M
Investing Cash Flow$ -959.00K$ -1.23M$ -172.00K$ 231.00K$ 57.00K
Financing Cash Flow$ -460.00K$ -4.86M$ 1.40M$ 42.20M$ -981.00K
Currency in USD

RVL Pharmaceuticals Earnings and Revenue History

RVL Pharmaceuticals Debt to Assets

RVL Pharmaceuticals Cash Flow

RVL Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis